Literature DB >> 28977594

DNA Sequence Constraints Define Functionally Active Steroid Nuclear Receptor Binding Sites in Chromatin.

Laurel A Coons1,2, Sylvia C Hewitt1, Adam B Burkholder3, Donald P McDonnell2, Kenneth S Korach1.   

Abstract

Gene regulatory programs are encoded in the sequence of the DNA. Since the completion of the Human Genome Project, millions of gene regulatory elements have been identified in the human genome. Understanding how each of those sites functionally contributes to gene regulation, however, remains a challenge for nearly every field of biology. Transcription factors influence cell function by interpreting information contained within cis-regulatory elements in chromatin. Whereas chromatin immunoprecipitation-sequencing has been used to identify and map transcription factor-DNA interactions, it has been difficult to assign functionality to the binding sites identified. Thus, in this study, we probed the transcriptional activity, DNA-binding competence, and functional activity of select nuclear receptor mutants in cellular and animal model systems and used this information to define the sequence constraints of functional steroid nuclear receptor cis-regulatory elements. Analysis of the architecture within sNR chromatin interacting sites revealed that only a small fraction of all sNR chromatin-interacting events is associated with transcriptional output and that this functionality is restricted to elements that vary from the consensus palindromic elements by one or two nucleotides. These findings define the transcriptional grammar necessary to predict functionality from regulatory sequences, with a multitude of future implications.
Copyright © 2017 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28977594      PMCID: PMC5659708          DOI: 10.1210/en.2017-00468

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  122 in total

1.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

Review 2.  Absence of a simple code: how transcription factors read the genome.

Authors:  Matthew Slattery; Tianyin Zhou; Lin Yang; Ana Carolina Dantas Machado; Raluca Gordân; Remo Rohs
Journal:  Trends Biochem Sci       Date:  2014-08-14       Impact factor: 13.807

3.  DNA binding of the glucocorticoid receptor is not essential for survival.

Authors:  H M Reichardt; K H Kaestner; J Tuckermann; O Kretz; O Wessely; R Bock; P Gass; W Schmid; P Herrlich; P Angel; G Schütz
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

4.  Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells.

Authors:  Duohui Jing; Vivek A Bhadri; Dominik Beck; Julie A I Thoms; Nurul A Yakob; Jason W H Wong; Kathy Knezevic; John E Pimanda; Richard B Lock
Journal:  Blood       Date:  2014-10-21       Impact factor: 22.113

5.  Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer.

Authors:  Zhong Chen; Xun Lan; Jennifer M Thomas-Ahner; Dayong Wu; Xiangtao Liu; Zhenqing Ye; Liguo Wang; Benjamin Sunkel; Cassandra Grenade; Junsheng Chen; Debra L Zynger; Pearlly S Yan; Jiaoti Huang; Kenneth P Nephew; Tim H-M Huang; Shili Lin; Steven K Clinton; Wei Li; Victor X Jin; Qianben Wang
Journal:  EMBO J       Date:  2014-12-22       Impact factor: 11.598

6.  Effects of multiple estrogen responsive elements, their spacing, and location on estrogen response of reporter genes.

Authors:  G Sathya; W Li; C M Klinge; J H Anolik; R Hilf; R A Bambara
Journal:  Mol Endocrinol       Date:  1997-12

7.  Nucleosome-driven transcription factor binding and gene regulation.

Authors:  Cecilia Ballaré; Giancarlo Castellano; Laura Gaveglia; Sonja Althammer; Juan González-Vallinas; Eduardo Eyras; Francois Le Dily; Roser Zaurin; Daniel Soronellas; Guillermo P Vicent; Miguel Beato
Journal:  Mol Cell       Date:  2012-11-21       Impact factor: 17.970

8.  Genomic redistribution of GR monomers and dimers mediates transcriptional response to exogenous glucocorticoid in vivo.

Authors:  Hee-Woong Lim; N Henriette Uhlenhaut; Alexander Rauch; Juliane Weiner; Sabine Hübner; Norbert Hübner; Kyoung-Jae Won; Mitchell A Lazar; Jan Tuckermann; David J Steger
Journal:  Genome Res       Date:  2015-05-08       Impact factor: 9.043

9.  Androgen receptor uses relaxed response element stringency for selective chromatin binding and transcriptional regulation in vivo.

Authors:  Biswajyoti Sahu; Päivi Pihlajamaa; Vanessa Dubois; Stefanie Kerkhofs; Frank Claessens; Olli A Jänne
Journal:  Nucleic Acids Res       Date:  2014-01-22       Impact factor: 16.971

10.  Design and analysis of ChIP-seq experiments for DNA-binding proteins.

Authors:  Peter V Kharchenko; Michael Y Tolstorukov; Peter J Park
Journal:  Nat Biotechnol       Date:  2008-11-16       Impact factor: 54.908

View more
  8 in total

Review 1.  Estrogen Receptors: New Directions in the New Millennium.

Authors:  Sylvia C Hewitt; Kenneth S Korach
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

2.  DNA methylation and transcriptome aberrations mediated by ERα in mouse seminal vesicles following developmental DES exposure.

Authors:  Yin Li; Katherine J Hamilton; Tianyuan Wang; Laurel A Coons; Wendy N Jefferson; Ruifang Li; Yu Wang; Sara A Grimm; J Tyler Ramsey; Liwen Liu; Kevin E Gerrish; Carmen J Williams; Paul A Wade; Kenneth S Korach
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-16       Impact factor: 11.205

3.  Estrogens Promote Misfolded Proinsulin Degradation to Protect Insulin Production and Delay Diabetes.

Authors:  Beibei Xu; Camille Allard; Ana I Alvarez-Mercado; Taylor Fuselier; Jun Ho Kim; Laurel A Coons; Sylvia C Hewitt; Fumihiko Urano; Kenneth S Korach; Ellis R Levin; Peter Arvan; Z Elizabeth Floyd; Franck Mauvais-Jarvis
Journal:  Cell Rep       Date:  2018-07-03       Impact factor: 9.423

4.  Functional Definition of Thyroid Hormone Response Elements Based on a Synthetic STARR-seq Screen.

Authors:  Frédéric Flamant; Yanis Zekri; Romain Guyot
Journal:  Endocrinology       Date:  2022-08-01       Impact factor: 5.051

5.  Activation of hepatic estrogen receptor-α increases energy expenditure by stimulating the production of fibroblast growth factor 21 in female mice.

Authors:  Camille Allard; Fabrice Bonnet; Beibei Xu; Laurel Coons; Diana Albarado; Cristal Hill; Guy Fagherazzi; Kenneth S Korach; Ellis R Levin; John Lefante; Christopher Morrison; Franck Mauvais-Jarvis
Journal:  Mol Metab       Date:  2019-02-14       Impact factor: 7.422

Review 6.  Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions.

Authors:  Adriana C Rodriguez; Zannel Blanchard; Kathryn A Maurer; Jason Gertz
Journal:  Horm Cancer       Date:  2019-02-02       Impact factor: 3.869

7.  The Lineage Determining Factor GRHL2 Collaborates with FOXA1 to Establish a Targetable Pathway in Endocrine Therapy-Resistant Breast Cancer.

Authors:  Kimberly J Cocce; Jeff S Jasper; Taylor K Desautels; Logan Everett; Suzanne Wardell; Thomas Westerling; Robert Baldi; Tricia M Wright; Kendall Tavares; Alex Yllanes; Yeeun Bae; Jeremy T Blitzer; Craig Logsdon; Daniel P Rakiec; David A Ruddy; Tiancong Jiang; Gloria Broadwater; Terry Hyslop; Allison Hall; Muriel Laine; Linda Phung; Geoffrey L Greene; Lesley-Ann Martin; Sunil Pancholi; Mitch Dowsett; Simone Detre; Jeffrey R Marks; Gregory E Crawford; Myles Brown; John D Norris; Ching-Yi Chang; Donald P McDonnell
Journal:  Cell Rep       Date:  2019-10-22       Impact factor: 9.423

Review 8.  Genome-wide crosstalk between steroid receptors in breast and prostate cancers.

Authors:  Ville Paakinaho; Jorma J Palvimo
Journal:  Endocr Relat Cancer       Date:  2021-07-22       Impact factor: 5.678

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.